ECL vs NPCE · P/E 35, rev $4.01B vs rev $100.0M
Ecolab Inc (ECL) versus Neuropace Inc (NPCE) — a side-by-side from cached financials, not a winner call.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Neuropace Inc (NPCE) is a medical devices company listed on US.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Latest reported NPCE revenue for 2025-12-31 was $100.0M. Net income was -$21.5M. Revenue was up 25.1% from 2024-12-31 to 2025-12-31. NPCE currently screens at market cap $312.2M.
ECL currently screens at market cap $72.05B and trailing P/E 34.6. NPCE currently screens at market cap $312.2M.
Not investment advice. Open the ECL and NPCE stock pages for the full models.
Not investment advice.